1. Home
  2. WDFC vs EWTX Comparison

WDFC vs EWTX Comparison

Compare WDFC & EWTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo WD-40 Company

WDFC

WD-40 Company

HOLD

Current Price

$231.76

Market Cap

3.4B

Sector

Industrials

ML Signal

HOLD

Logo Edgewise Therapeutics Inc.

EWTX

Edgewise Therapeutics Inc.

HOLD

Current Price

$40.63

Market Cap

3.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WDFC
EWTX
Founded
1953
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.4B
3.7B
IPO Year
1995
2021

Fundamental Metrics

Financial Performance
Metric
WDFC
EWTX
Price
$231.76
$40.63
Analyst Decision
Strong Buy
Buy
Analyst Count
2
6
Target Price
$270.00
$39.00
AVG Volume (30 Days)
180.3K
1.1M
Earning Date
04-09-2026
05-07-2026
Dividend Yield
1.91%
N/A
EPS Growth
30.92
N/A
EPS
5.02
N/A
Revenue
$488,109,000.00
N/A
Revenue This Year
$8.23
N/A
Revenue Next Year
$5.85
N/A
P/E Ratio
$46.34
N/A
Revenue Growth
19.49
N/A
52 Week Low
$175.38
$12.31
52 Week High
$298.90
$48.40

Technical Indicators

Market Signals
Indicator
WDFC
EWTX
Relative Strength Index (RSI) 44.34 52.30
Support Level $192.20 $37.81
Resistance Level $249.89 $43.93
Average True Range (ATR) 10.36 2.69
MACD -3.42 -0.52
Stochastic Oscillator 2.07 29.06

Price Performance

Historical Comparison
WDFC
EWTX

About WDFC WD-40 Company

WD-40 Co is a global marketing organization focused on developing and selling products that solve maintenance and cleaning problems internationally. It offers two product groups: maintenance products, including the flagship WD-40 Multi-Use Product, which serves as a lubricant, rust preventative, penetrant, and moisture displacer, marketed globally; and homecare and cleaning products, mainly sold in North America, the UK, and Australia. The company distributes its products through hardware stores, automotive parts outlets, industrial suppliers, mass retailers, online platforms, and specialty retailers across the Americas, EIMEA, and Asia-Pacific, with the majority of revenue generated in the Americas.

About EWTX Edgewise Therapeutics Inc.

Edgewise Therapeutics Inc is a clinical-stage biopharmaceutical company. It is developing novel therapeutics for muscular dystrophies and serious cardiac conditions. The company's product candidates are Sevasemten, EDG-7500, EDG-003, and EDG-15400. Sevasemten is an orally administered small molecule designed to address the root cause of dystrophinopathies, including Duchenne muscular dystrophy (Duchenne) and Becker muscular dystrophy (Becker). The company's products are currently in different stages of their development, being developed to target key muscle proteins and modulators to address a broad array of muscle diseases.

Share on Social Networks: